The U.S. Food and Drug Administration today approved Actemra (tocilizumab), given alone or in combination with methotrexate, for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in children ages 2 years and older.
Archives
- May 2022
- April 2022
- March 2022
- February 2022
- December 2021
- December 2020
- June 2020
- February 2018
- March 2015
- July 2014
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009